Bionano Genomics Insider Trades
NASDAQ: BNGOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $9.70K
- Sales
- 0 · $0
- Shares bought / sold
- 8.00K / 0
- Net activity
- Net buying $9,705
Bionano Genomics insider activity
Over the last 12 months, Bionano Genomics insiders reported 11 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $9,705 and sold $0 worth of stock, for net insider buying of $9,705. The most recent filing shows Luderer Albert (Interim Chief Executive) buying 4,000 shares at $1.21 on Sep 4, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BNGO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BNGO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 4, 2026 | Luderer AlbertInterim Chief Executive | Buy | 4,000 | $4.84K | Form 4 |
| Aug 21, 2026 | Luderer AlbertInterim Chief Executive | Buy | 4,000 | $4.86K | Form 4 |
| Jun 3, 2026 | Adamchak MarkPrincipal Accounting Officer | Tax withholding | 7 | $9.10 | Form 4 |
| Jun 3, 2026 | Chaubey AlkaCHIEF MEDICAL OFFICER | Tax withholding | 24 | $31.20 | Form 4 |
| Jun 3, 2026 | OLDAKOWSKI MARKCHIEF OPERATING OFFICER | Tax withholding | 27 | $35.10 | Form 4 |
| Jun 3, 2026 | Dixon Jonathan V.GENERAL COUNSEL | Tax withholding | 24 | $31.20 | Form 4 |
| Feb 17, 2026 | Holmlin R. ErikPRESIDENT AND CEO | Tax withholding | 51 | $56.10 | Form 4 |
| Feb 17, 2026 | OLDAKOWSKI MARKCHIEF OPERATING OFFICER | Tax withholding | 20 | $22 | Form 4 |
| Feb 17, 2026 | Dixon Jonathan V.GENERAL COUNSEL | Tax withholding | 6 | $6.60 | Form 4 |
| Feb 17, 2026 | Chaubey AlkaCHIEF MEDICAL OFFICER | Tax withholding | 18 | $19.80 | Form 4 |
| Feb 17, 2026 | Adamchak MarkPrincipal Accounting Officer | Tax withholding | 3 | $3.30 | Form 4 |
| Sep 11, 2025 | Chaubey AlkaChief Medical Officer | Tax withholding | 51 | $207.06 | Form 4 |
| Sep 11, 2025 | OLDAKOWSKI MARKChief Operating Officer | Tax withholding | 59 | $239.54 | Form 4 |
| Sep 11, 2025 | OLDAKOWSKI MARKChief Operating Officer | Tax withholding | 59 | $239.54 | Form 4 |
| Jun 3, 2025 | Dixon Jonathan V.General Counsel | Tax withholding | 25 | $92.25 | Form 4 |
| Jun 3, 2025 | Holmlin R. ErikPresident and CEO | Tax withholding | 75 | $276.75 | Form 4 |
| Jun 3, 2025 | Chaubey AlkaChief Medical Officer | Tax withholding | 24 | $88.56 | Form 4 |
| Jun 3, 2025 | OLDAKOWSKI MARKChief Operating Officer | Tax withholding | 27 | $99.63 | Form 4 |
| Jun 3, 2025 | Adamchak MarkPrincipal Accounting Officer | Tax withholding | 7 | $25.83 | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4